Phase 2
Pulmonary Hypertension
Intervention Type:
Oral Drug
Funder Type:
Organization | University

Drug Details

H01 (Hymecromone) is an oral drug approved in Europe for biliary spasm treatment.

Study Purpose

This study is a prospective, randomized, double-blind, study of H01 (Hymecromone) in adults with pulmonary hypertension (PH). The primary objective of this study is to evaluate the safety and tolerability of oral H01 and the potential benefit of oral H01 on clinical measures of PH disease severity over 24 weeks.

Find a Clinical Trial